Cargando…

Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs). There is scant literature on the characteristics and causes of these conditions among the Nigerian population. Here, we describe the epidemiology, associated morbidity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshikoya, Kazeem Adeola, Ogunyinka, Ibrahim Abayomi, Ogar, Comfort Kunak, Abiola, Abiodun, Ibrahim, Ali, Oreagba, Ibrahim Adekunle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016315/
https://www.ncbi.nlm.nih.gov/pubmed/32110375
http://dx.doi.org/10.1177/2042098620905998
_version_ 1783496961145438208
author Oshikoya, Kazeem Adeola
Ogunyinka, Ibrahim Abayomi
Ogar, Comfort Kunak
Abiola, Abiodun
Ibrahim, Ali
Oreagba, Ibrahim Adekunle
author_facet Oshikoya, Kazeem Adeola
Ogunyinka, Ibrahim Abayomi
Ogar, Comfort Kunak
Abiola, Abiodun
Ibrahim, Ali
Oreagba, Ibrahim Adekunle
author_sort Oshikoya, Kazeem Adeola
collection PubMed
description BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs). There is scant literature on the characteristics and causes of these conditions among the Nigerian population. Here, we describe the epidemiology, associated morbidity and mortality, and culpable drugs in SJS and TEN cases using the National Pharmacovigilance (NPC) database in Nigeria. METHODS: A retrospective review of the NPC database was done to analyze SJS and TEN cases reported over a period of 14 years. Annual reports, age and sex of patients, type of reporter, suspects and concomitant drugs, time to onset (TTO) of the reactions, and outcome of SJS and TEN were evaluated. RESULTS: The NPC received a total of 24,015 adverse drug reaction (ADR) reports. SJS and TEN accounted for 284 (0.1%) of the total reports, of which 254 (89.4%) were SJS and the remainder were TEN. Females (n = 184, 64.8%) and individuals aged 19–40 years (n = 181, 63.7%) were the most affected by SJS and TEN. Antiretrovirals, followed by antibiotics, were the most common drug classes reported to cause SJS and TEN, with nevirapine (n = 174, 40.7%) and co-trimoxazole (n = 143, 33.5%) being the most widely implicated drugs. Among patients with reported outcomes, 73 (28.7%) SJS and 3 (10.0%) TEN cases recovered without sequelae, at the time of reporting. Severity of the SCAR was reported for only 171 (69.0%) cases, of which 12 (4.7%) and 8 (26.7%) resulted in death (Grade 5) among SJS and TEN cases, respectively. CONCLUSIONS: Antiretroviral and antibiotics were the commonly reported offending group of drugs for SJS and TEN cases. Nevirapine and co-trimoxazole were the commonly reported suspect drugs. SJS and TEN were reported most frequently in females and in patients aged 19–40 years, indicating that drug surveillance and counseling in these groups of patients may be beneficial.
format Online
Article
Text
id pubmed-7016315
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-70163152020-02-27 Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017 Oshikoya, Kazeem Adeola Ogunyinka, Ibrahim Abayomi Ogar, Comfort Kunak Abiola, Abiodun Ibrahim, Ali Oreagba, Ibrahim Adekunle Ther Adv Drug Saf Original Research BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs). There is scant literature on the characteristics and causes of these conditions among the Nigerian population. Here, we describe the epidemiology, associated morbidity and mortality, and culpable drugs in SJS and TEN cases using the National Pharmacovigilance (NPC) database in Nigeria. METHODS: A retrospective review of the NPC database was done to analyze SJS and TEN cases reported over a period of 14 years. Annual reports, age and sex of patients, type of reporter, suspects and concomitant drugs, time to onset (TTO) of the reactions, and outcome of SJS and TEN were evaluated. RESULTS: The NPC received a total of 24,015 adverse drug reaction (ADR) reports. SJS and TEN accounted for 284 (0.1%) of the total reports, of which 254 (89.4%) were SJS and the remainder were TEN. Females (n = 184, 64.8%) and individuals aged 19–40 years (n = 181, 63.7%) were the most affected by SJS and TEN. Antiretrovirals, followed by antibiotics, were the most common drug classes reported to cause SJS and TEN, with nevirapine (n = 174, 40.7%) and co-trimoxazole (n = 143, 33.5%) being the most widely implicated drugs. Among patients with reported outcomes, 73 (28.7%) SJS and 3 (10.0%) TEN cases recovered without sequelae, at the time of reporting. Severity of the SCAR was reported for only 171 (69.0%) cases, of which 12 (4.7%) and 8 (26.7%) resulted in death (Grade 5) among SJS and TEN cases, respectively. CONCLUSIONS: Antiretroviral and antibiotics were the commonly reported offending group of drugs for SJS and TEN cases. Nevirapine and co-trimoxazole were the commonly reported suspect drugs. SJS and TEN were reported most frequently in females and in patients aged 19–40 years, indicating that drug surveillance and counseling in these groups of patients may be beneficial. SAGE Publications 2020-02-12 /pmc/articles/PMC7016315/ /pubmed/32110375 http://dx.doi.org/10.1177/2042098620905998 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Oshikoya, Kazeem Adeola
Ogunyinka, Ibrahim Abayomi
Ogar, Comfort Kunak
Abiola, Abiodun
Ibrahim, Ali
Oreagba, Ibrahim Adekunle
Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
title Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
title_full Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
title_fullStr Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
title_full_unstemmed Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
title_short Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
title_sort severe cutaneous adverse drug reactions manifesting as stevens-johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in nigeria: a database review from 2004 to 2017
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016315/
https://www.ncbi.nlm.nih.gov/pubmed/32110375
http://dx.doi.org/10.1177/2042098620905998
work_keys_str_mv AT oshikoyakazeemadeola severecutaneousadversedrugreactionsmanifestingasstevensjohnsonsyndromeandtoxicepidermalnecrolysisreportedtothenationalpharmacovigilancecenterinnigeriaadatabasereviewfrom2004to2017
AT ogunyinkaibrahimabayomi severecutaneousadversedrugreactionsmanifestingasstevensjohnsonsyndromeandtoxicepidermalnecrolysisreportedtothenationalpharmacovigilancecenterinnigeriaadatabasereviewfrom2004to2017
AT ogarcomfortkunak severecutaneousadversedrugreactionsmanifestingasstevensjohnsonsyndromeandtoxicepidermalnecrolysisreportedtothenationalpharmacovigilancecenterinnigeriaadatabasereviewfrom2004to2017
AT abiolaabiodun severecutaneousadversedrugreactionsmanifestingasstevensjohnsonsyndromeandtoxicepidermalnecrolysisreportedtothenationalpharmacovigilancecenterinnigeriaadatabasereviewfrom2004to2017
AT ibrahimali severecutaneousadversedrugreactionsmanifestingasstevensjohnsonsyndromeandtoxicepidermalnecrolysisreportedtothenationalpharmacovigilancecenterinnigeriaadatabasereviewfrom2004to2017
AT oreagbaibrahimadekunle severecutaneousadversedrugreactionsmanifestingasstevensjohnsonsyndromeandtoxicepidermalnecrolysisreportedtothenationalpharmacovigilancecenterinnigeriaadatabasereviewfrom2004to2017